|
4-butyl-1,2-diphenyl-5-hydroxy-3-oxo-pyrazolidine compd. with 1-benzyl-3,3-(dimethylamino)propoxy-1H-indazole
|
CHEM:Pharmacologic Substance |
|
|
butazidamine
|
CHEM:Pharmacologic Substance |
|
|
LS 701
|
CHEM:Pharmacologic Substance |
|
|
2-N-butoxy-7,10-dichloropyrido(3,2-b)quinoline
|
CHEM:Pharmacologic Substance |
|
|
WR 10,488
|
CHEM:Pharmacologic Substance |
|
|
WR 10488
|
CHEM:Pharmacologic Substance |
|
|
WR-10488
|
CHEM:Pharmacologic Substance |
|
|
4-(4-tert-butylbenzoyl)-3-methyl-1-phenyl-2-pyrazolin-5-one
|
CHEM:Pharmacologic Substance |
|
|
4-(p-tert-butylbenzoyl)-3-methyl-1-phenyl-2-pyrazolin-5-one
|
CHEM:Pharmacologic Substance |
|
|
sodium 2-(carboxymethylmercapto)benzene stibonate
|
CHEM:Pharmacologic Substance |
|
|
Captostibone (g)
|
CHEM:Pharmacologic Substance |
|
|
carnitylcholine
|
CHEM:Pharmacologic Substance |
|
|
2-chloro-4-acetylaminobenzonitrile
|
CHEM:Pharmacologic Substance |
|
|
BW 63-307
|
CHEM:Pharmacologic Substance |
|
|
BW-63-307
|
CHEM:Pharmacologic Substance |
|
